Patent · US Active

Heterocyclic compounds and uses thereof

US8940742B2 · kind B2 · utility

30Cited by

204References

48Claims

0Family size

Assignee

Infinity Pharmaceuticals, Inc. · US

Inventors

Alfredo C. Castro · Woburn, US
Katrina Chan · Fremont, US
Catherine A. Evans · Somerville, US
Somarajannair Janardanannair · Woburn, US
Andre Lescarbeau · Somerville, US
Liansheng Li · San Diego, US
Tao Liu · Shanghai, CN
Yi Liu · San Diego, US
Pingda Ren · San Diego, US
Daniel A. Snyder · Somerville, US
Martin Tremblay · Waltham, US

Key dates

Filing date	Mar 15, 2013
Grant date	Jan 27, 2015
Priority date	—
Expiry date	Mar 15, 2033

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds and pharmaceutical compositions that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including PI3 kinase activity, are described herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.